
Infinitopes secures funding to develop cancer vaccine
Biotechnology company Infinitopes has raised $35.1 million in a seed financing round to accelerate the development of a precision cancer vaccine. The latest finance round was co-led by Octopus Ventures and new investor Amplify Bio, with further participation from new investor Macmillan Cancer Support and existing investors Cancer Research Horizons and Manta… Read More















